News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Insights
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Insights
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Bavarian Nordic Issues Revised Financial Calendar for 2013
December 21, 2012
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
KVISTGAARD, Denmark, December 21, 2012 - Bavarian Nordic A/S (OMX: BAVA) announced today a revised financial calendar for the year 2013. The company has moved the announcement of the 2012 Annual Report from 7 March 2013 to 12 March 2013.
Twitter
LinkedIn
Facebook
Email
Print
Europe
MORE ON THIS TOPIC
Business
US biotechs take lion’s share of $54.5B VC money raised since 2025
October 26, 2026
·
1 min read
·
Gabrielle Masson
Policy
Roche flags ‘final opportunity’ for Germany to reestablish as a reliable investment location
October 23, 2026
·
2 min read
·
Nick Paul Taylor
Manufacturing
Sanofi breaks ground on insulin plant after securing German government support
October 19, 2026
·
2 min read
·
Nick Paul Taylor
cancer
Merck/Moderna, Summit/Akeso and ADCs to headline ESMO 2026
October 19, 2026
·
8 min read
·
Tristan Manalac
